Newron Pharmaceuticals S.p.A. Stock Chart

Newron Pharmaceuticals S.p.A. (XETR) · Health Technology. stock live price and technical analysis view. Follow XETRA data on Alerta Chart.

Checking data access...

About Newron Pharmaceuticals S.p.A.

XETR
Market Cap
272.47M
P/E Ratio
10.63
Shares Out.
19.96M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

www.newron.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
NP5.DE (NP5.DE) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart